May 17, 2013 9:34 AM
The North Chicago, IL-based drug giant and Belgium's Galapagos have agreed to expand their collaboration on an oral JAK1 inhibitor to include Crohn's disease.
read more >
May 17, 2013 9:32 AM
In a Friday announcement, Novo Nordisk said it completed the first phase III trial of its drug N9-GP for hemophilia B patients.
read more >
May 16, 2013 6:00 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit. The study -- to...
read more >
May 16, 2013 6:00 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!In a new discovery reported in the Journal of Biological Chemistry, Brown University and Lifespan researchers show that in the brain cells of rats, obesity impedes the production of a hormone that curbs appetite...
read more >
May 16, 2013 6:00 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!The relationship between the heritable risk for schizophrenia and low intelligence (IQ) has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional disability...
read more >
May 17, 2013 12:15 PM
US CRO PRA is proposing to go public again, more than six years since it was taken private, according to a confidential draft registration statement submitted to the US SEC.
read more >
May 16, 2013 6:31 AM
Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex.
read more >
May 16, 2013 2:04 AM
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Theorem and Symbiosis.
read more >
May 17, 2013 2:34 AM
Trillium Therapeutics, a wholly owned subsidiary of Stem Cell Therapeutics, has completed dosing of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) in first phase study of TTI-1612.
read more >
May 17, 2013 2:33 AM
Evotec and Harvard University have entered into research collaboration to develop new class of antibacterials.
read more >
May 17, 2013 12:37 AM
Helsinn Healthcare and Vifor Pharma have signed a licensing and distribution deal for netupitant-palonosetron fixed dose combination (NEPA) in Switzerland, France, Spain, Portugal, the Netherlands, Belgium and Luxembourg.
read more >